Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2
Joseph Newman, Nazia Thakur, Thomas P. Peacock, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19

Showing 19 citing articles:

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1161-1179
Open Access | Times Cited: 531
The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 253
The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism
Brian J. Willett, Joe Grove, Oscar A. MacLean, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 135
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
Daniel J. Sheward, Chang-Il Kim, Roy A. Ehling, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 813-820
Open Access | Times Cited: 81
Analysis of SARS-CoV-2 Omicron Neutralization Data up to 2022-01-28
Antonia Netzl, Sina Türeli, Eric B. LeGresley, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 29
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 16
Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
Qianqian Li, Mingjie Zhang, Ziteng Liang, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 26
SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges
Nazia Thakur, Giulia Gallo, Joseph Newman, et al.
Journal of General Virology (2022) Vol. 103, Iss. 4
Open Access | Times Cited: 23
Aerosolized Ad5-nCoV booster vaccination elicited potent immune response against the SARS-CoV-2 Omicron variant after inactivated COVID-19 vaccine priming
Zhe Zhang, Shipo Wu, Yawei Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5
Brian J. Willett, Ashwini Kurshan, Nazia Thakur, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 15
A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial
Yu Cao, Xiaoli Wang, Siqi Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 8, pp. 1677-1679
Open Access | Times Cited: 10
Propylene glycol inactivates respiratory viruses and prevents airborne transmission
Christine T. Styles, Jie Zhou, Katie E. Flight, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 12
Open Access | Times Cited: 5
Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern
Jinal N. Bhiman, Penny L. Moore
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 61-75
Open Access | Times Cited: 8
Omicron breakthrough infections in vaccinated or previously infected hamsters
Jie Zhou, Ksenia Sukhova, Paul F. McKay, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Propylene glycol inactivates respiratory viruses and prevents airborne transmission
Christine T. Styles, Jie Zhou, Katie E. Flight, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium
Diana Erazo, María F. Vincenti‐González, Joris Adriaan Frank van Loenhout, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1315-1315
Open Access | Times Cited: 1
ChAdOx1 nCoV-19 vaccination generates spike-specific CD8+ T cells in aged mice
William S. Foster, Nazia Thakur, Joseph Newman, et al.
Authorea (Authorea) (2023)
Open Access
ChAdOx1 nCoV‐19 vaccination generates spike‐specific CD8+ T cells in aged mice
William S. Foster, Joseph Newman, Nazia Thakur, et al.
Immunology and Cell Biology (2023) Vol. 101, Iss. 6, pp. 479-488
Open Access
Antibody Persistence after Primary Sars-Cov-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
Felicity Aiano, Georgina Ireland, Frances Baawuah, et al.
SSRN Electronic Journal (2022)
Open Access
Page 1

Scroll to top